LAUREN HANIFY: Open Payments
NPI 1528500766 · MARTHASVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 34 payments from 17 companies in 2025. Trend: 2023 $252 · 2024 $113 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
Products named: Korlym, CAPLYTA, SPRAVATO, JARDIANCE, REXULTI, BREZTRI, MOUNJARO, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
